Background and Objectives: The watch‐and‐wait (WW) strategy is a nonsurgical alternative for patients with rectal cancer exhibiting an excellent response to chemoradiotherapy. Studies on the WW strategy have primarily investigated 5‐year oncological outcomes; few have focused on longer‐term outcomes or the optimal patient selection approach for this therapeutic strategy. Methods: This retrospective study enrolled patients with locally advanced rectal adenocarcinoma who had achieved complete response after chemoradiotherapy. Patients who achieved pathological complete response were categorized into a control group ( n = 95) and those who achieved clinical complete response and were managed using the WW strategy were categorized into a case group ( n = 33). Kaplan–Meier estimates were calculated for the between‐group comparison of survival. Results: The median follow‐up duration was 89 months. Compared with the control group, the case group exhibited improved long‐term sphincter preservation, particularly for low‐lying tumors ( p = 0.032), and inferior nonlocal‐regrowth disease‐free survival ( p = 0.007). Within the case group, patients achieving a complete response by positron emission tomography exhibited 5‐year survival rates similar to those achieving a complete endoscopic response. Conclusion: The WW strategy is associated with improved sphincter preservation but worse nonlocal‐regrowth disease‐free survival. The potential of PET in patient selection for this strategy deserves further investigation.